NASDAQ:SWAVShockwave Medical Stock Price, Forecast & News

Shockwave Medical's stock was trading at $34.44 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SWAV stock has increased by 38.4% and is now trading at $47.68. View which stocks have been most impacted by Coronavirus.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Shockwave Medical.

Shockwave Medical is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Shockwave Medical.

Shockwave Medical Inc (NASDAQ:SWAV) released its quarterly earnings results on Tuesday, May, 12th. The company reported ($0.59) earnings per share for the quarter, missing analysts' consensus estimates of ($0.49) by $0.10. The business earned $15.20 million during the quarter, compared to analysts' expectations of $14.17 million. Shockwave Medical had a negative net margin of 112.25% and a negative return on equity of 38.18%. The business's quarterly revenue was up 109.1% on a year-over-year basis. During the same period last year, the business posted ($1.37) EPS. View Shockwave Medical's earnings history.

7 brokers have issued 1-year price objectives for Shockwave Medical's stock. Their forecasts range from $23.00 to $54.00. On average, they anticipate Shockwave Medical's stock price to reach $44.86 in the next twelve months. This suggests that the stock has a possible downside of 5.9%. View analysts' price targets for Shockwave Medical.

News stories about SWAV stock have been trending negative on Wednesday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Shockwave Medical earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news about Shockwave Medical.

Shockwave Medical saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 3,850,000 shares, a decrease of 5.6% from the June 15th total of 4,080,000 shares. Based on an average daily volume of 412,900 shares, the days-to-cover ratio is presently 9.3 days. Approximately 14.8% of the company's shares are short sold. View Shockwave Medical's Current Options Chain.

Some companies that are related to Shockwave Medical include Haemonetics (HAE), Globus Medical (GMED), Integra Lifesciences (IART), Nevro (NVRO), ICU Medical (ICUI), Inovio Pharmaceuticals (INO), Irhythm Technologies (IRTC), NuVasive (NUVA), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP), Inari Medical (NARI), Cantel Medical (CMD), AtriCure (ATRC), Glaukos (GKOS) and Luminex (LMNX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), salesforce.com (CRM), Alibaba Group (BABA), Walt Disney (DIS), Trade Desk (TTD), Roku (ROKU), Paypal (PYPL), Square (SQ), Twilio (TWLO) and Shopify (SHOP).

(SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SWAV stock can currently be purchased for approximately $47.68.

Shockwave Medical has a market capitalization of $1.52 billion and generates $42.93 million in revenue each year. The company earns $-51,110,000.00 in net income (profit) each year or ($2.14) on an earnings per share basis. Shockwave Medical employs 162 workers across the globe.

The official website for Shockwave Medical is www.shockwavemedical.com.

Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at 510-279-4262 or via email at [email protected]